Exhaled nitric oxide levels in children with chronic adenotonsillar disease

Area of Science:

• Pediatric Otolaryngology
• Respiratory Medicine
• Biomedical Science

Background:

• Exhaled nitric oxide (eNO) is a biological mediator linked to adult chronic tonsillar disease.
• Limited data exists on eNO levels in pediatric chronic tonsillar conditions.
• Understanding eNO in children with adenotonsillar issues is crucial for diagnosis and management.

Purpose of the Study:

• To measure mean eNO levels in children with chronic adenotonsillitis and adenotonsillar hypertrophy.
• To investigate the influence of confounding factors on eNO levels in these pediatric groups.
• To compare eNO levels between children with chronic adenotonsillitis, adenotonsillar hypertrophy, and healthy controls.

Main Methods:

• Recruitment of children aged 3-17 years into three groups: chronic adenotonsillitis, adenotonsillar hypertrophy, and controls.
• Standardized measurement of exhaled nitric oxide (eNO) levels according to international guidelines.
• Collection of clinical data, including age, allergy status, body mass index, and adenoidal/tonsillar hypertrophy grade.

Main Results:

• Mean eNO levels were slightly higher in children with chronic adenotonsillitis but without statistical significance.
• No significant difference in mean eNO levels was observed between the chronic adenotonsillitis and adenotonsillar hypertrophy groups.
• Age, allergy, and body mass index were statistically associated with mean eNO levels, unlike the grade of tonsillar hypertrophy.

Conclusions:

• Preliminary findings suggest no significant elevation of mean eNO levels in pediatric chronic adenotonsillar disease.
• eNO levels in children with chronic adenotonsillitis are comparable to those with adenotonsillar hypertrophy.
• Further research is needed to elucidate the role of eNO in pediatric tonsillar and adenoid conditions.